Cyclic lipodepsipeptides as lead structures for the discovery of new antiobiotics
With antimicrobial resistance to current drugs steadily rising, the development of new antibiotics with novel mechanisms of action has become an imperative. The majority of life-threatening infections worldwide are caused by "ESKAPE" pathogens which are encountered in more than 40% of hosp...
Other Authors: | Bionda, Nina. |
---|---|
Format: | Others |
Language: | English |
Published: |
Florida Atlantic University
|
Subjects: | |
Online Access: | http://purl.flvc.org/FAU/3360768 |
Similar Items
-
Development and testing of liposome encapsulated cyclic dipeptides
by: Kilian, Gareth
Published: (2011) -
The comparison of biological properties of L- and D-enantiomeric antimicrobial peptides
by: Kwok, Hoi-shan, et al.
Published: (2014) -
Antibacterial activity of liposome encapsulated cyclo(TYR-PRO)
by: Tshanga, Siphokazi Sisanda
Published: (2011) -
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
by: Charles H. Chen, et al.
Published: (2020-01-01) -
Studies on Efrapeptins
by: Uma, M V.
Published: (2011)